Astrid Eder

2.0k total citations
17 papers, 1.6k citations indexed

About

Astrid Eder is a scholar working on Molecular Biology, Immunology and Cell Biology. According to data from OpenAlex, Astrid Eder has authored 17 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Immunology and 3 papers in Cell Biology. Recurrent topics in Astrid Eder's work include Sphingolipid Metabolism and Signaling (5 papers), Immune Cell Function and Interaction (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Astrid Eder is often cited by papers focused on Sphingolipid Metabolism and Signaling (5 papers), Immune Cell Function and Interaction (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Astrid Eder collaborates with scholars based in United States, Spain and Germany. Astrid Eder's co-authors include Gordon B. Mills, Muling Mao, Xianjun Fang, Jonathan D. Ashwell, Lourdes Domínguez, Robert C. Bast, Takayo Sasagawa, Shuangxing Yu, Leslie B. King and Junken Aoki and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Astrid Eder

17 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Astrid Eder United States 14 1.3k 308 293 259 233 17 1.6k
Muling Mao United States 14 1.3k 1.0× 167 0.5× 227 0.8× 501 1.9× 222 1.0× 16 1.7k
Roberta Bortul Italy 26 1.7k 1.3× 238 0.8× 220 0.8× 349 1.3× 219 0.9× 60 2.2k
Richard I. Feldman United States 11 1.3k 1.0× 158 0.5× 347 1.2× 524 2.0× 209 0.9× 15 1.8k
Matthew N. Hodgkin United Kingdom 16 1.2k 0.9× 198 0.6× 419 1.4× 144 0.6× 103 0.4× 32 1.5k
Masahiro Sonoshita Japan 15 816 0.6× 388 1.3× 146 0.5× 675 2.6× 351 1.5× 28 1.9k
S Nishibe United States 15 1.5k 1.2× 266 0.9× 373 1.3× 377 1.5× 108 0.5× 23 2.0k
Nicole R. Murray United States 26 1.4k 1.1× 178 0.6× 273 0.9× 637 2.5× 381 1.6× 47 2.1k
Alyssa E. Johnson United States 17 1.0k 0.8× 157 0.5× 281 1.0× 344 1.3× 501 2.2× 44 1.5k
Megumi Iiizumi United States 17 1.1k 0.8× 222 0.7× 152 0.5× 494 1.9× 674 2.9× 19 1.7k
Keitaro Hayashi Japan 20 669 0.5× 496 1.6× 104 0.4× 252 1.0× 183 0.8× 55 1.4k

Countries citing papers authored by Astrid Eder

Since Specialization
Citations

This map shows the geographic impact of Astrid Eder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Astrid Eder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Astrid Eder more than expected).

Fields of papers citing papers by Astrid Eder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Astrid Eder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Astrid Eder. The network helps show where Astrid Eder may publish in the future.

Co-authorship network of co-authors of Astrid Eder

This figure shows the co-authorship network connecting the top 25 collaborators of Astrid Eder. A scholar is included among the top collaborators of Astrid Eder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Astrid Eder. Astrid Eder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Estrella, Verónica, Astrid Eder, Shuying Liu, et al.. (2007). Lysophosphatidic acid induction of urokinase plasminogen activator secretion requires activation of the p38MAPK pathway. International Journal of Oncology. 31(2). 441–9. 29 indexed citations
2.
Eder, Astrid, Xiaomei Sui, Daniel Rosen, et al.. (2005). Atypical PKCι contributes to poor prognosis through loss of apical-basal polarity and Cyclin E overexpression in ovarian cancer. Proceedings of the National Academy of Sciences. 102(35). 12519–12524. 188 indexed citations
3.
Mills, Gordon B., Xianjun Fang, Yiling Lu, et al.. (2003). Specific Keynote: Molecular Therapeutics in Ovarian Cancer. Gynecologic Oncology. 88(1). S88–S92. 21 indexed citations
4.
Hasegawa, Yutaka, James R. Erickson, Shuangxing Yu, et al.. (2003). Identification of a Phosphothionate Analogue of Lysophosphatidic Acid (LPA) as a Selective Agonist of the LPA3 Receptor. Journal of Biological Chemistry. 278(14). 11962–11969. 109 indexed citations
5.
Tanyi, János L., Ruth LaPushin, Astrid Eder, et al.. (2002). Identification of Tissue- and Cancer-Selective Promoters for the Introduction of Genes into Human Ovarian Cancer Cells. Gynecologic Oncology. 85(3). 451–458. 17 indexed citations
6.
Erickson, James R., Yutaka Hasegawa, Xianjun Fang, et al.. (2001). Lysophosphatidic acid and ovarian cancer: a paradigm for tumorogenesis and patient management. Prostaglandins & Other Lipid Mediators. 64(1-4). 63–81. 22 indexed citations
7.
Mills, Gordon B., Yiling Lu, Xianjun Fang, et al.. (2001). The role of genetic abnormalities of PTEN and the phosphatidylinositol 3-kinase pathway in breast and ovarian tumorigenesis, prognosis, and therapy. Seminars in Oncology. 28(5N). 125–141. 12 indexed citations
8.
Fang, Xianjun, Douglas C. Gaudette, Tatsuro Furui, et al.. (2000). Lysophospholipid Growth Factors in the Initiation, Progression, Metastases, and Management of Ovarian Cancer. Annals of the New York Academy of Sciences. 905(1). 188–208. 211 indexed citations
9.
Eder, Astrid, et al.. (2000). Constitutive and lysophosphatidic acid (LPA)-induced LPA production: role of phospholipase D and phospholipase A2.. PubMed. 6(6). 2482–91. 142 indexed citations
10.
Fang, Xianjun, Shuangxing Yu, Astrid Eder, et al.. (1999). Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathway. Oncogene. 18(48). 6635–6640. 236 indexed citations
11.
Yang, Yili, et al.. (1999). Bacterial death induced by expression of the intracellular portion of human Fas. Cell Death and Differentiation. 6(8). 805–812. 2 indexed citations
12.
Pustilnik, Terri, Verónica Estrella, Jon R. Wiener, et al.. (1999). Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells.. PubMed. 5(11). 3704–10. 137 indexed citations
13.
Eder, Astrid, Lourdes Domínguez, Thomas Franke, & Jonathan D. Ashwell. (1998). Phosphoinositide 3-Kinase Regulation of T Cell Receptor-mediated Interleukin-2 Gene Expression in Normal T Cells. Journal of Biological Chemistry. 273(43). 28025–28031. 65 indexed citations
14.
Domínguez, Lourdes, et al.. (1997). Lack of a Role for Jun Kinase and AP-1 in Fas-Induced Apoptosis. Molecular and Cellular Biology. 17(1). 170–181. 233 indexed citations
15.
Debatin, Klaus‐Michael, et al.. (1995). Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemias. Blood. 85(6). 1562–1569. 129 indexed citations
16.
Li‐Weber, Min, et al.. (1992). T cell-specific negative regulation of transcription of the human cytokine IL-4. The Journal of Immunology. 148(6). 1913–1918. 59 indexed citations
17.
Eder, Astrid, et al.. (1988). Hie 5′ region of the human interleukin 4 gene: structure and potential regulatory elements. Nucleic Acids Research. 16(2). 772–772. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026